(Reuters Health) – A pregnant woman who becomes ill from the Zika virus faces a 7 percent chance that her child will be born with birth defects, and that risk jumps to nearly 13 percent if she becomes ill during the first trimester, a new study conducted in French territories in the Americas has concluded.
Source: Reuters Medical News
(Reuters Health) – Patients with private health insurance often face high out-of-pocket fees for advanced imaging, a U.S. study suggests.
Source: Reuters Medical News
(Reuters) – South Dakota on Wednesday sued three major drugmakers, accusing them of deceptively marketing prescription opioids and contributing to a nationwide epidemic.
Source: Reuters Medical News
(Reuters Health) – Older women with breast cancer who live in United States territories are less likely than their peers in the continental U.S. to receive recommended care, a study suggests.
Source: Reuters Medical News
(Reuters Health) – When one-half of a couple embraces good health, there’s a higher likelihood that the other half will, too, a recent study suggests.
Source: Reuters Medical News
(Reuters Health) – Smokers may be more likely to develop hearing loss than nonsmokers, and the risk increases with each additional cigarette people smoke on a typical day, a Japanese study suggests.
Source: Reuters Medical News
(Reuters Health) – A team of Bolivian women are using indigenous Aymara weaving patterns to craft devices that can help repair heart defects, doctors involved in developing the device report in JAMA.
Source: Reuters Medical News
(Reuters Health) – The U.S. spends about twice what other high-income nations do on health care but has the lowest life expectancy and the highest infant mortality rates, a new study suggests.
Source: Reuters Medical News
(Reuters Health) – Insurance companies may be asking people to shell out more money for drug co-payments than the drugs actually cost, a new study suggests.
Source: Reuters Medical News
BRUSSELS (Reuters) – Israeli drugmaker Teva rebuffed EU antitrust charges of making an illegal deal with rival Cephalon to delay selling a cheaper generic version of the latter’s sleep disorder drug at a hearing on Tuesday.
Source: Reuters Medical News